All data are based on the daily closing price as of March 2, 2026
l

L&C Bio

290650.KQ
68.51 USD
0.52
+0.76%

Overview

Last close
68.51 usd
Market cap
1.69B usd
52 week high
81.75 usd
52 week low
10.84 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
29.9732
Price/Book Value
9.3587
Enterprise Value
1.68B usd
EV/Revenue
30.6306
EV/EBITDA
16.7856

Key financials

Revenue TTM
52.15M usd
Gross Profit TTM
25.63M usd
EBITDA TTM
3.89M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
355.50M usd
Net debt
45.16M usd

About

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C Bio Co., Ltd was founded in 2011 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    290650.KQ
  • Exchange
    KQ
  • Isin
    KR7290650001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Mr. Chul Lee Whan
  • Headquarter
    Seongnam-si
  • Web site
    https://www.lncbio.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top